Search Filters:

The items contained in the list are being used to filter the search results. Click them to remove them from the search filter.
Displaying 1 - 20 of 874
PIPS Search Results
PIP Number Active Substance Conditions / Indications Invented Name Therapeutic area Decision Type Compliance Check Compliance outcome Date Published Sort ascending
MHRA-100137-PIP01-21-M04 (update)
  • linaclotide
  • Treatment of functional constipation
  • Constella
  • Constella
  • Constella
  • Constella
  • Constella
  • Constella
  • Gastroenterology-Hepatology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-100209-PIP01-21-M03 (update)
  • survodutide
  • Treatment of obesity
  • Not available at present
  • Gastroenterology-Hepatology
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-102483-PIP01-26
  • Efimosfermin alfa
  • Treatment of alcohol-related liver disease
  • Gastroenterology-Hepatology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-100646-PIP01-22-M03 (update)
  • TOLVAPTAN
  • Treatment of dilutional hyponatraemia
  • Treatment of polycystic kidney disease
  • Samsca
  • Jinarc
  • Samsca
  • Jinarc
  • Uro-Nephrology
  • Endocrinology-Gynaecology-Fertility-metabolism
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-100178-PIP01-21-M01 (update)
  • pariglasgene brecaparvovec (DTX401)
  • Treatment of glycogen storage disease type 1a (GSDIa)
  • Endocrinology-Gynaecology-Fertility-metabolism
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-102236-PIP01-25
  • Enicepatide
  • Treatment of Type 2 Diabetes Mellitus
  • Endocrinology-Gynaecology-Fertility-metabolism
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-100349-PIP01-26
  • Rezafungin acetate
  • Prevention of invasive fungal infections
  • Rezzayo
  • Rezzayo
  • Rezzayo
  • Rezzayo
  • Infectious diseases
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-100164-PIP01-21-M06 (update)
  • Nirmatrelvir
  • RITONAVIR
  • Treatment of coronavirus disease 2019 (COVID-19)
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Paxlovid
  • Infectious diseases
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101091-PIP01-23-M01 (update)
  • Borrelia outer surface protein A (OspA) serotypes (ST1- 6) lipidated, fusion protein vaccine (VLA15 - PF07307405)
  • Prevention of Lyme disease
  • Vaccines
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-102423-PIP01-26
  • elegrobart
  • Treatment of thyroid eye disease
  • Elegrobart
  • Endocrinology-Gynaecology-Fertility-metabolism
  • Ophthamology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101785-PIP01-25-M01 (update)
  • Repinatrabit
  • Treatment of hyperphenylalaninemia
  • Endocrinology-Gynaecology-Fertility-metabolism
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-101174-PIP01-23-M01 (update)
  • LENACAPAVIR SODIUM
  • Lenacapavir
  • Prevention of human immunodeficiency virus (HIV-1) infection
  • Sunlenca
  • Yeytuo
  • Sunlenca
  • Yeytuo
  • Sunlenca
  • Yeytuo
  • Infectious diseases
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-102482-PIP01-26
  • Human rabies immune globulin
  • Prevention of rabies infection
  • KAMRAB
  • KAMRAB
  • KAMRAB
  • PlasmaRAB
  • KAMRAB
  • KAMRAB
  • REBINOLIN
  • KAMRAB
  • REBINOLIN
  • KEDRAB
  • Infectious diseases
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-101583-PIP01-24-M02 (update)
  • Recombinant Varicella Zoster Virus Glycoprotein E
  • Prevention of varicella zoster virus (VZV) reactivation
  • Shingrix
  • Shingrix
  • Shingrix
  • Vaccines
PM: decision on the application for modification of an agreed paediatric investigation plan. No
MHRA-102213-PIP01-25
  • Ianalumab
  • Treatment of systemic lupus erythematosus
  • Immunology -Rheumatology-Transplantation
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-100278-PIP01-21
  • Venglustat
  • Treatment of Fabry disease
  • Endocrinology-Gynaecology-Fertility-metabolism
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-102256-PIP01-25
  • Divesiran
  • Treatment of polycythaemia vera
  • Haematology-Hemostaseology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101943-PIP01-25
  • Adimanebart
  • Treatment of spinal muscular atrophy
  • Neurology
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-102231-PIP01-25
  • 13 Grass Aqueous Extract
  • Treatment of allergic rhinitis / rhino-conjunctivitis
  • Grassmuno
  • Pneumology - Allergology
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) No
MHRA-100312-PIP01-21-M03 (update)
  • RITLECITINIB TOSYLATE
  • Treatment of alopecia areata
  • Litfulo
  • Litfulo
  • Litfulo
  • Dermatology
PM: decision on the application for modification of an agreed paediatric investigation plan. No